PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17591773-3	2007	The human aldo-keto reductase AKR7A2 has been proposed previously to catalyze the NADPH-dependent reduction of succinic semialdehyde (SSA) to GHB in human brain.	NADP	82-87	aldo-keto reductase family 7 member A2	Homo sapiens	30-36	
7424738-7	1980	The fourth human brain enzyme ("SSA reductase") differs from the other forms in its ability to use NADH as well as or better than NADPH as cofactor, and in its molecular weight, which is nearly twice that of the other forms.	NADP	130-135	aldo-keto reductase family 7 member A2	Homo sapiens	17-46	
9576847-7	1998	Although the two AKR7 proteins are predicted to possess distinct secondary structural features which distinguish them from the prototypic AKR1 family of AKRs, the catalytic- and NADPH-binding residues appear to be conserved in both families.	NADP	178-183	aldo-keto reductase family 7 member A2	Homo sapiens	17-21	
11409944-7	2001	One enzyme induced by cancer chemopreventive agents is AFB1 aldehyde reductase (AFAR), which catalyzes the NADPH-dependent reduction of the dialdehyde to a dialcohol.	NADP	107-112	aldo-keto reductase family 7 member A2	Homo sapiens	55-78	
11409944-7	2001	One enzyme induced by cancer chemopreventive agents is AFB1 aldehyde reductase (AFAR), which catalyzes the NADPH-dependent reduction of the dialdehyde to a dialcohol.	NADP	107-112	aldo-keto reductase family 7 member A2	Homo sapiens	80-84